Ministry of Agriculture Announcement on the Release of the Results of the First Veterinary Drug Quality Inspection in 2007 -- 2007

　　Ministry of Agriculture Announcement on the Release of the First Issue of 2007

　　Notice on the Results of Veterinary Drug Quality Spot Checks

　　To the Animal Husbandry and Veterinary (Agriculture, Farming) Departments (Bureaus, Offices) of all provinces, autonomous regions, and municipalities directly under the Central Government:

　　In accordance with the unified deployment of our Ministry, various localities have completed the 2006 fourth-quarter veterinary drug (excluding veterinary biological products, hereinafter the same) quality supervision and spot-check plan. The spot-check results are reported as follows.

　　I. Basic Situation and Existing Problems

　　This spot check covered 5332 batches of veterinary drug products, with 4117 batches passing, resulting in a pass rate of 77.2%. This is 0.6 percentage points higher than the third quarter and 4.4 percentage points higher than the same period in 2005. Among them, 517 batches were checked at the production stage, with a pass rate of 97.1%, which is 0.4 percentage points lower than the third quarter; 4236 batches were checked at the business stage, with a pass rate of 75.0%, which is 2.9 percentage points higher than the third quarter; 579 batches were checked at the usage stage, with a pass rate of 75.5%, which is 1.5 percentage points higher than the third quarter; and 194 batches of veterinary drugs for aquatic products were checked, with a pass rate of 68.0%, which is 17.3 percentage points lower than the third quarter (summary table of unqualified products see Attachment 1).

　　This spot check covered veterinary drug products from 28 provinces, and there were significant differences in the quality of veterinary drugs checked in each province (pass rates of veterinary drugs in each province see Attachment 2). According to the principles of key monitoring enterprises, 23 veterinary drug production enterprises, including Beijing Kexing Pharmaceutical Co., Ltd., were identified as key monitoring enterprises (see Attachment 3).

　　The spot check results show that the main quality problems of veterinary drugs in the fourth quarter are as follows: First, illegal production is prominent, with a total of 133 batches of fake veterinary drugs, accounting for 17.6% of the total number of unqualified products. Among them, 74 batches were fake veterinary drugs that imitated legitimate enterprises, and 41 batches were products from illegal veterinary drug enterprises, accounting for 9.5% of the total number of unqualified products. Second, insufficient content and intentional falsification are prominent. Third, some banned veterinary drugs and products listed in the announcement of the abolition of local veterinary drug standards and whose market circulation period has expired are still circulating and used in the market. Fourth, the proportion of fake and inferior veterinary drugs in the business and use stages is still relatively high.

　　II. Handling Opinions on Unqualified Products and Related Enterprises

　　(1) Jinan Guta Veterinary Drug Co., Ltd., listed in Attachment 3, was again included in the key monitoring scope during the appeal period, with a cumulative total of 32 unqualified batches. According to the regulations, our Ministry will revoke its "Veterinary Drug Production License" in accordance with the law. Inventory products produced by this enterprise before the release of this notice must be sold only after passing the inspection by the provincial veterinary drug supervision office.

　　(2) For the other 22 key monitoring enterprises listed in Attachment 3, the provincial-level veterinary administrative departments where they are located should organize special supervision and inspection and impose administrative penalties in accordance with the law. For serious problems, the penalty should be increased, and penalties such as suspension of production for rectification and cancellation of product approval numbers should be imposed in accordance with the law. The results of the penalties should be reported to the Veterinary Bureau of our Ministry.

　　(3) For the production enterprises listed in Attachment 1, the provincial-level veterinary administrative departments where they are located should supervise the enterprises to conduct self-examination and rectification. For those who intentionally falsify, they should be severely punished in accordance with the law. They should supervise the destruction of unqualified inventory products, recall and destroy the unqualified products that have been sold according to sales records, and promptly inform the veterinary administrative departments where the purchasers are located of the sales information of unqualified products, so that they can organize the confiscation.

　　(4) For those marked with "no such enterprise" or "no such product" in the "unqualified items" column of Attachment 1, and which have been verified and confirmed to be counterfeit enterprises or counterfeit products, localities should conduct case investigation, track down and destroy the counterfeiting dens. For cross-provincial crimes, the relevant provincial-level veterinary administrative departments should be promptly informed, and active cooperation should be carried out to conduct joint investigations into the cases.

　　(5) For veterinary drug business enterprises or user units listed in the "sampled units" column of Attachment 1, the veterinary administrative departments where they are located should organize inspections, and for those who intentionally deal in fake and inferior veterinary drugs and whose circumstances are serious, their "Veterinary Drug Business Licenses" should be revoked in accordance with the law. The unqualified products listed in this notice should be promptly confiscated and destroyed, and the illegal supply channels should be tracked down.

　　(6) For key monitoring enterprises during the monitoring period and enterprises that have been found to have serious illegal and irregular behaviors, our Ministry will not accept their applications for changes to their "Veterinary Drug Production Licenses".

　　(7) Within 30 working days of the release of this notice, localities should report the handling of unqualified products and related enterprises to the Veterinary Bureau of our Ministry.

　　III. Appeal Verification Results and Handling Opinions

　　According to the relevant regulations on the appeal and verification of veterinary drug quality spot checks, after verification and confirmation of the appeal materials on veterinary drug quality spot checks recently submitted by various localities, some unqualified products in the 2006 annual veterinary drug quality spot check report were counterfeit products or had incorrect testing standards. The specific situation is shown in the "Veterinary Drug Supervision Spot Check Verification Catalog" (Attachment 4, hereinafter referred to as the "Verification Catalog"). The enterprises involved in the above products shall be handled according to the following principles:

　　(1) According to the principles of veterinary drug quality verification, Henan Zhongya Shenpeng Animal Pharmaceutical Co., Ltd., Hebei Huaqiang Animal Pharmaceutical Co., Ltd., Shangqiu Huakang Animal Pharmaceutical Co., Ltd., and Baoding Jizhong Veterinary Drug Factory will not be included in the 2006 annual key monitoring enterprise scope.

　　(2) The relevant responsibilities of the enterprises whose products are listed in the "Verification Catalog" will no longer be pursued.

　　(3) Localities should increase the efforts to confiscate counterfeit products listed in the "Verification Catalog" and use this as a clue to seriously investigate and destroy the counterfeiting dens. As the main body responsible for the quality of veterinary drugs, veterinary drug production enterprises should actively cooperate with veterinary administrative departments in cracking down on fake and inferior veterinary drugs while standardizing their production activities and ensuring product quality, jointly creating a good atmosphere for industry development, and promoting the healthy development of the veterinary drug industry.